The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
CD105 is important for angiogenesis: evidence and potential applications
Abstract
Angiogenesis is the propelling force for tumor growth and metastasis, and antiangiogenic therapy represents one of the most promising modalities for cancer treatment. CD105 (endoglin) is a proliferation‐associated and hypoxia‐inducible protein abundantly expressed in angiogenic endothelial cells (EC). It is a receptor for transforming growth factor (TGF) ‐β1 and ‐β3 and modulates TGF‐β signaling by interacting with TGF‐β receptors I and/or II. Immunohistochemistry studies have revealed that CD105 is strongly expressed in blood vessels of tumor tissues. Intratumoral microvessel density (MVD) determined using antibodies to CD105 has been found to be an independent prognostic indicator, wherein increased MVD correlates with shorter survival. CD105 is able to be shed into the circulation, with elevated levels detected in patients with various types of cancer and positively correlated with tumor metastasis. Tangible evidence of its proangiogenic role comes from knockout studies in which CD105 null mice die in utero as a result of impaired angiogenesis in the yolk sac and heart defects. The potential usefulness of CD105 for tumor imaging has been evaluated in tumor‐bearing mice and dogs that have shown the rapid accumulation of radiolabeled anti‐CD105 monoclonal antibody in the tumors with a high tumor‐to‐background ratio. The anti‐CD105 antibody conjugated with immunotoxins and immunoradioisotopes efficiently suppressed/abrogated tumor growth in murine models bearing breast and colon carcinoma without any significant systemic side effects. Immunoscintigraphy in patients with renal cell carcinomas has shown specific localization of 99 Tc m ‐labeled CD105 mab in tumor endothelial cells. Thus, CD105 is a promising vascular target that can be used for tumor imaging, prognosis, and bears therapeutic potential in patients with solid tumors and other angiogenic diseases.—Duff, S. E., Li, C., Garland, J. M., Kumar, S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J. 17, 984–992 (2003)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrel, J., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-345 · Cited by 1,482
Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S.-J., Stenzel, T. T., Speer, M., Pericak-Vance, M. A., Diamond, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-189 · Cited by 1,116
Defective Angiogenesis in Mice Lacking Endoglin
Li, D. Y., Sorensen, L. K., Brooke, B. S., Urness, L. D., Davis, E. C., Taylor, D. G., Boak, B. B., & Wendel, D. P. (1999) · Science · doi:10.1126/science.284.5419.1534 · Cited by 852
Cheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabeu, C., Massagué, J., & Letarte, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41732-2 · Cited by 836
Horak, E. R., Klenk, N., Leek, R., LeJeune, S., Smith, K., Stuart, N., Harris, A. L., Greenall, M., & Stepniewska, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)93150-l · Cited by 800
Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., Mcculloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., et al. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00379-6 · Cited by 729
Barbara, N. P., Wrana, J. L., & Letarte, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.584 · Cited by 565
Srivastava, A., Laidler, P., Davies, R. P., Horgan, K. J., & Hughes, L. E. (1988) · PubMed Central · Cited by 528
Role of Transforming Growth Factor-beta Signaling in Cancer
de Caestecker, M. P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.17.1388 · Cited by 522
Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.
Lawler, J., Weinstein, R., & Hynes, R. O. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2351 · Cited by 474
A murine model of hereditary hemorrhagic telangiectasia
Bourdeau, A., Dumont, D. J., & Letarte, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8088 · Cited by 468
Arthur, H. M., Ure, J., Smith, A. J. H., Renforth, G., Wilson, D. I., Torsney, E., Charlton, R., Parums, D. V., Jowett, T., Marchuk, D. A., et al. (2000) · Developmental Biology · doi:10.1006/dbio.1999.9534 · Cited by 436
Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.
Kumar, S., Ghellal, A., Li, C., Byrne, G. J., Haboubi, N. Y., Wang, J. M., & Bundred, N. J. (1999) · PubMed · Cited by 361
Self-citationBurrows, F. J., Derbyshire, E. J., Tazzari, P. L., Amlot, P. L., Gazdar, A. F., King, S. W., Letarte, M., Vitetta, E. S., & Thorpe, P. E. (1995) · PubMed · Cited by 334
Sánchez-Elsner, T., Botella, L. M., Velasco, B., Langa, C., & Bernabéu, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207160200 · Cited by 326
Endoglin modulates cellular responses to TGF-beta 1.
Lastres, P., Letamendía, A., Zhang, H., Rius, C., Almendro, N., Raab, U., López, L. A., Langa, C., Fabra, A., Letarte, M., et al. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.5.1109 · Cited by 304
Tanaka, F., Otake, Y., Yanagihara, K., Kawano, Y., Miyahara, R., Li, M., Yamada, T., Hanaoka, N., Inui, K., & Wada, H. (2001) · PubMed · Cited by 274
Gougos, A., & Letarte, M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.6.1925 · Cited by 254
LI, C., HAMPSON, I. N., HAMPSON, L., KUMAR, P., BERNABEU, C., & KUMAR, S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.55 · Cited by 230
Self-citationRegulated expression on human macrophages of endoglin, an Arg‐Gly‐Asp‐containing surface antigen
Lastres, P., Bellon, T., Cabañas, C., Sanchez‐Madrid, F., Acevedo, A., Gougos, A., Letarte, M., & Bernabeu, C. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220216 · Cited by 227
Role of Endoglin in Cellular Responses to Transforming Growth Factor-β
Letamendı́a, A., Lastres, P., Botella, L. M., Raab, U., Langa, C., Velasco, B., Attisano, L., & Bernabeu, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33011 · Cited by 224
Guerrero-Esteo, M., Sánchez-Elsner, T., Letamendia, A., & Bernabéu, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111991200 · Cited by 219
Bellón, T., Corbi, A., Lastres, P., Calés, C., Cebrián, M., Vera, S., Cheifetz, S., Massague, J., Letarte, M., & Bernabéu, C. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230943 · Cited by 215
Miller, D. W., Graulich, W., Karges, B., Stahl, S., Ernst, M., Ramaswamy, A., Sedlacek, H.-H., M�ller, R., & Adamkiewicz, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990517)81:4<568::aid-ijc11>3.0.co;2-x · Cited by 196
Shyu, K.-G., Wang, M.-T., Wang, B.-W., Chang, C.-C., Leu, J.-G., Kuan, P., & Chang, H. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00259-6 · Cited by 185
Gougos, A., St Jacques, S., Greaves, A., O'Connell, P. J., d'Apice, A. J. F., Bühring, H.-J., Bernabeu, C., van Mourik, J. A., & Letarte, M. (1992) · International Immunology · doi:10.1093/intimm/4.1.83 · Cited by 184
A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues
Wang, J. M., Kumar, S., Pye, D., Krupinski, J., Hunter, R. D., & Van Agthoven, A. J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540303 · Cited by 183
Self-citationSeon, B. K., Matsuno, F., Haruta, Y., Kondo, M., & Barcos, M. P. (1997) · PubMed · Cited by 166
Takahashi, N., Haba, A., Matsuno, F., & Seon, B. K. (2001) · PubMed · Cited by 150
Matsuno, F., Haruta, Y., Kondo, M., Tsai, H., Barcos, M. P., & Seon, B. K. (1999) · PubMed · Cited by 144
Abdalla, S. A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1227 · Cited by 137
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules
Kay, N. E., Bone, N. D., Tschumper, R., Howell, K., Geyer, S., Dewald, G., Hanson, C., & Jelinek, D. (2002) · Leukemia · doi:10.1038/sj.leu.2402467 · Cited by 135
Fonsatti, E., Jekunen, A. P., Kairemo, K., et al. (2000) · PubMed · Cited by 135
Breast Carcinoma: Comparative Study of Tummor Vasculature Using Two Endothelial Cell Markers
Wang, J. M., Kumar, S. S., Pye, D. A., et al. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.386 · Cited by 126
Self-citationTakahashi, N. K., Kawanishi‐Tabata, R., Haba, A., Tabata, M., Haruta, Y., Tsai, H., & Seon, B. K. (2001) · PubMed · Cited by 124
Endoglin-deficient Mice, a Unique Model to Study Hereditary Hemorrhagic Telangiectasia
Bourdeau, A. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00062-7 · Cited by 121
Pece-Barbara, N., Cymerman, U., Vera, S., Marchuk, D. A., & Letarte, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2171 · Cited by 120
Bourdeau, A., Faughnan, M. E., McDonald, M., Paterson, A. D., Wanless, I. R., & Letarte, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64673-1 · Cited by 113
Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglin
Bredow, S., Lewin, M., Hofmann, B., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00335-4 · Cited by 113
Rı́us, C., Smith, J. D., Almendro, N., Langa, C., Botella, L. M., Marchuk, D. A., Vary, C., & Bernabéu, C. (1998) · Blood · doi:10.1182/blood.v92.12.4677 · Cited by 111
Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts
Guerrero-Esteo, M., Lastres, P., Letamendía, A., Pérez-Álvarez, M. J., Langa, C., López, L. A., Fabra, À., García-Pardo, A., Vera, S., Letarte, M., et al. (1999) · European Journal of Cell Biology · doi:10.1016/s0171-9335(99)80046-6 · Cited by 101
Akagi, K., Ikeda, Y., Sumiyoshi, Y., et al. (2002) · Surgery · doi:10.1067/msy.2002.119361 · Cited by 95
Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow.
Bühring, H., Müller, C. A., Letarte, M., Gougos, A., Saalmüller, A., Agthoven, A. V., & Busch, F. W. (1991) · PubMed · Cited by 92
Paquet, M.-È. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.13.1347 · Cited by 91
Endoglin expression as a measure of microvessel density in cervical cancer
Brewer, C. A. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00864-4 · Cited by 85
Botella, L. M., Sánchez-Elsner, T., Rı́us, C., Corbí, A. L., & Bernabéu, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011611200 · Cited by 78
Phosphorylation of the human-transforming-growth-factor-β-binding protein endoglin
Lastres, P., Martín-Pérez, J., Langa, C., & Bernabéu, C. (1994) · Biochemical Journal · doi:10.1042/bj3010765 · Cited by 76
Strategies for vascular targeting in tumors
Brekken, R. A., Li, C., & Kumar, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10462 · Cited by 59
Self-citationMolecular Defects in Rare Bleeding Disorders: Hereditary Haemorrhagic Telangiectasia
Shovlin, C. L. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657518 · Cited by 59
New strategies in anti‐vascular cancer therapy
Bloemendal, Logtenberg, & Voest (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00534.x · Cited by 55
Mast cells in the pathogenesis of chronic back pain: a hypothesis
Freemont, A. J., Jeziorska, M., Hoyland, J. A., Rooney, P., & Kumar, S. (2002) · The Journal of Pathology · doi:10.1002/path.1107 · Cited by 47
Self-citationSystemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane
Ribatti, D., Cantatore, F. P., Vacca, A., D’Amore, S., Ria, R., Roncali, L., & Pipitone, V. (1998) · Clinical Rheumatology · doi:10.1007/bf01452256 · Cited by 19
Re: Role of Transforming Growth Factor- Signaling in Cancer
Li, C., Garland, J. M., & Kumar, S. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.7.555 · Cited by 8
Self-citation
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Ultrasound Microbubble Contrast Agents: Fundamentals and Application to Gene and Drug Delivery
Ferrara, K., Pollard, R., & Borden, M. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095852 · Cited by 1,288
Extracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
TGF-β signaling in vascular biology and dysfunction
Goumans, M.-J., Liu, Z., & ten Dijke, P. (2009) · Cell Research · doi:10.1038/cr.2008.326 · Cited by 601
TGF-? receptor function in the endothelium
LEBRIN, F., DECKERS, M., BERTOLINO, P., & TENDIJKE, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.036 · Cited by 513
Metadata
- Authors
- DUFF, S. E., LI, C., GARLAND, J. M., & KUMAR, S.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-06
- Volume
- 17
- Issue
- 9
- Pages
- 984-992
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2023949193
- Cited by
- 556
- References
- 59
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.